• Profile
Close

Persistent low-level viremia while on antiretroviral therapy is an independent risk factor for virologic failure

Clinical Infectious Diseases Mar 08, 2019

Joya C, et al. - Using data from the U.S. Military HIV Natural History Study (NHS), researchers examined if persistent low-level viremia (pLLV) is associated with virologic failure (VF). They included 2006 subjects in whom initiation of combination antiretroviral therapy (ART) was undertaken with two or more VLs measures with a lower limit of detection of <50 copies/mL. A confirmed VL ≥200 copies/mL or any VL>1000 copies/mL that defined VF was reported in 383 subjects (19%). pLLV (3.46) and hLV (2.29) were noted to be associated with VF after adjusting for demographics, VL, CD4 counts, ART regimen, prior use of mono or dual antiretrovirals, and time to ART start. Data thereby support the evidence suggesting deleterious virologic consequences in correlation with persistent LLV.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay